Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
Top Cited Papers
Open Access
- 3 May 2013
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 120 (9), 1860-1870
- https://doi.org/10.1016/j.ophtha.2013.01.073
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Optical Coherence Tomography Grading Reproducibility during the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2012
- Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular DegenerationOphthalmology, 2012
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year ResultsOphthalmology, 2012
- Photographic Assessment of Baseline Fundus Morphologic Features in the Comparison of Age-related Macular Degeneration Treatments TrialsOphthalmology, 2012
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2011
- Angiographic and Optical Coherence Tomographic Results of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular DegenerationOphthalmology, 2007
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- A computerized method of visual acuity testing: Adaptation of the early treatment of diabetic retinopathy study testing protocolAmerican Journal of Ophthalmology, 2003
- Robust Locally Weighted Regression and Smoothing ScatterplotsJournal of the American Statistical Association, 1979